Physiotherpay assessment and management of muscular dystrophy in detail

Reading Document
Medical Text Search

physiotherapy assessment muscular dystrophy functional evaluation

Medical Text Search

physiotherapy management rehabilitation muscular dystrophy exercise respiratory

GradeResponse
GradeResponse
The retrieved documents are limited, so I will deliver a comprehensive answer from established clinical knowledge, supplemented by the retrieved reference.

Physiotherapy Assessment & Management of Muscular Dystrophy

Overview

Muscular dystrophies (MDs) are a heterogeneous group of inherited myopathies characterized by progressive skeletal muscle weakness and degeneration. The most clinically significant types include:
TypeInheritanceOnsetKey Features
Duchenne (DMD)X-linked recessive2–5 yrsSevere, rapidly progressive; Gowers' sign
Becker (BMD)X-linked recessive5–15 yrsMilder DMD variant
Limb-Girdle (LGMD)AR / ADVariableProximal limb-girdle weakness
Facioscapulohumeral (FSHD)ADTeens–30sFace, shoulder girdle, foot dorsiflexors
Myotonic (DM1/DM2)ADVariableMyotonia, distal weakness, multisystem
Emery-Dreifuss (EDMD)X-linked/AD/ARChildhoodEarly contractures, cardiac conduction defects
Congenital (CMD)ARBirth–infancyHypotonia, structural CNS changes possible
A multidisciplinary approach is essential across all types, with physiotherapy being a cornerstone at every disease stage (Bailey & Love's Short Practice of Surgery, 28th ed., p. 652).

Part 1: Physiotherapy Assessment

1.1 Initial History Taking

  • Chief complaint: nature and onset of weakness, falls, difficulty rising from floor
  • Functional history: loss of milestones (children), ADL limitations, stair climbing, wheelchair use
  • Respiratory history: dyspnea, sleep disturbance, morning headaches, recurrent chest infections
  • Family history: genetic pedigree
  • Medical/surgical history: corticosteroid use, cardiac investigations, orthopaedic surgeries
  • Medications: corticosteroids (deflazacort, prednisolone in DMD), heart medications
  • Psychosocial history: school/work participation, caregiver burden, quality of life

1.2 Musculoskeletal Assessment

Muscle Strength Testing

ToolDetails
Manual Muscle Testing (MMT)MRC 0–5 scale; graded proximally and distally
Handheld Dynamometry (HHD)Quantitative, reproducible; preferred for serial monitoring
Isokinetic DynamometryResearch/specialized settings
Key muscle groups to assess:
  • Hip flexors, extensors, abductors
  • Knee flexors and extensors
  • Ankle dorsiflexors and plantarflexors
  • Shoulder abductors, elbow flexors/extensors
  • Neck flexors (often early weakness in myotonic dystrophy)
  • Grip and pinch strength

Range of Motion (ROM) and Flexibility

  • Goniometry for all major joints
  • Prone hip extension, Thomas test, popliteal angle
  • Ankle dorsiflexion ROM — critical predictor of ambulation loss
  • Contractures: hip flexors, knee flexors, Achilles tendon (most common in DMD)
  • Spine: thoracolumbar scoliosis screening — Cobb angle measurement referral if suspected

Posture and Alignment

  • Lumbar hyperlordosis (compensatory in proximal weakness)
  • Pelvic tilt, winging of scapulae (FSHD)
  • Leg length discrepancy
  • Foot deformities: equinovarus, pes planus

1.3 Functional Assessments

Assessment ToolPurpose
Timed Tests
10-Metre Walk Test (10MWT)Gait speed, ambulation capacity
Timed Up and Go (TUG)Mobility, dynamic balance
6-Minute Walk Test (6MWT)Submaximal exercise capacity, endurance
10-Metre Run/WalkDMD-specific; sensitive to change
Rising from FloorGowers' sign timing; functional floor transfer ability
Stair Climbing4-stair climb time (DMD natural history outcome)
Upper Limb Function
Performance of Upper Limb (PUL)Validated for DMD, non-ambulant stage
9-Hole Peg TestFine motor and hand dexterity
Box & Block TestGross manual dexterity
Disease-Specific Scales
North Star Ambulatory Assessment (NSAA)17-item validated scale for ambulant DMD
Hammersmith Functional Motor Scale (HFMS)Non-ambulant neuromuscular conditions
Motor Function Measure (MFM-32)Across all MD types, 3 domains
Vignos ScaleFunctional ambulation staging in DMD
Brooke ScaleUpper limb functional staging

1.4 Gait Analysis

  • Observational gait analysis: Trendelenburg gait (hip abductor weakness), equinus, toe-walking, waddling/Duchenne gait
  • Instrumented gait analysis (where available): kinematics, kinetics, EMG
  • Energy expenditure during ambulation
  • Assistive device assessment (crutches, rollator, KAFOs)
  • Footwear and orthotic review

1.5 Respiratory Assessment

Respiratory involvement is a major cause of morbidity and mortality, especially in DMD, CMD, and Emery-Dreifuss MD.
AssessmentNormalAction Threshold
Spirometry (FVC)>80% predictedFVC <50%: refer to respiratory team
FVC supine vs. sitting<10% difference>10% drop suggests diaphragmatic weakness
Peak Cough Flow (PCF)>360 L/min<270 L/min: assisted cough needed; <160 L/min: ineffective cough
MIP (Max Inspiratory Pressure)VariableLow MIP: inspiratory muscle weakness
MEP (Max Expiratory Pressure)VariableLow MEP: impaired cough, secretion clearance
SpO₂ monitoring≥95%Overnight oximetry for nocturnal hypoventilation
Nocturnal capnographyCO₂ <45 mmHgElevated: NIV indicated
  • Screen for symptoms of nocturnal hypoventilation: morning headaches, fatigue, poor sleep
  • Assess secretion management: cough effectiveness, sputum volume

1.6 Spinal and Postural Assessment

  • Scoliosis: common in DMD post-ambulation loss (~90% develop scoliosis after wheelchair use)
  • Adam's forward bend test as screening tool
  • Refer for radiological Cobb angle if suspected
  • Kyphosis in FSHD, myotonic dystrophy
  • Cervical and thoracic extensor weakness

1.7 Pain Assessment

  • Often underreported in MD
  • Musculoskeletal pain from overuse, poor posture, contractures
  • Neuropathic pain (myotonic dystrophy)
  • VAS / NRS / Brief Pain Inventory

1.8 Activity and Participation (ICF Framework)

Using the International Classification of Functioning, Disability and Health (ICF):
  • Body function/structure: strength, ROM, respiratory function
  • Activity: ADLs, mobility, self-care
  • Participation: school, work, social interaction
  • Environmental factors: home accessibility, equipment, support
  • Personal factors: motivation, coping, self-efficacy
Tools: Paediatric Evaluation of Disability Inventory (PEDI), ACTIVLIM, SF-36, EQ-5D

Part 2: Physiotherapy Management

Management should be staged according to disease progression and tailored to the specific MD type.

2.1 Staging Framework

StageCharacteristicsPT Focus
Stage 1 (Early ambulant)Mild weakness, independent ambulationStretching, strengthening, activity promotion
Stage 2 (Late ambulant)Difficulty running, climbing stairsMaintain ambulation, orthoses, respiratory monitoring
Stage 3 (Early non-ambulant)Wheelchair dependentUL function, seating, respiratory support
Stage 4 (Late non-ambulant)Severe weakness, limited ULRespiratory management, positioning, comfort

2.2 Exercise Therapy

Strengthening Exercise

  • Submaximal, low-resistance exercise is safe; eccentric overload and high-intensity exercise is contraindicated — dystrophic muscle is vulnerable to contraction-induced injury
  • Recommended intensity: ≤60% of 1-RM, avoiding exhaustion
  • Circuit training, aquatic therapy, functional strengthening are preferred
  • Frequency: 3x/week; avoid exercise-induced fatigue
  • Aquatic/Hydrotherapy: buoyancy reduces joint loading; warmth reduces spasticity; improves strength, ROM, and mood; recommended especially when land-based exercise is difficult

Aerobic/Cardiovascular Exercise

  • Low-to-moderate intensity aerobic training improves cardiorespiratory fitness without accelerating muscle degeneration
  • Cycling (active or passive), swimming, walking
  • Target: 50–70% max heart rate
  • Monitor for fatigue, myalgia, or dark urine (myoglobinuria) as signs of overexertion

Evidence Summary

Exercise TypeRecommendationEvidence
Submaximal aerobic exerciseRecommendedModerate
Assisted cyclingRecommendedModerate
Aquatic therapyRecommendedModerate
Maximal eccentric loadingContraindicatedStrong
Prolonged immobility/bedrestAvoidStrong

2.3 Contracture Prevention and Stretching

Contractures accelerate loss of ambulation and impair positioning.
Daily passive stretching program:
  • Ankle plantarflexors (gastrocnemius-soleus): critical in DMD
  • Hip flexors: prone lying ≥30 min/day
  • Knee flexors (hamstrings)
  • Wrist flexors (myotonic dystrophy)
  • Elbow flexors, finger flexors (late stages)
Technique:
  • Slow, sustained stretch, 20–30 seconds per repetition, 3–5 reps
  • Never force to the point of pain
  • Use prolonged positioning (standing frames, splints) as adjuncts
Prolonged Positioning:
  • Night splints (AFOs): maintain ankle dorsiflexion, delay Achilles contracture
  • Standing frames/tilt tables: weight-bearing to reduce lower limb contractures, maintain bone density, improve bowel function
  • Prone lying: counteracts hip flexor and knee flexor contractures

2.4 Orthotic Management

OrthosisPurpose
Ankle-Foot Orthosis (AFO)Foot drop correction, prevent equinus contracture, improve gait
Knee-Ankle-Foot Orthosis (KAFO)Prolong ambulation in late ambulant stage
Spinal orthosis (TLSO)Scoliosis management in non-ambulant (limited evidence for curve correction but may aid seating)
Wrist-hand orthosisMaintain hand position, reduce contracture
Cervical collarNeck extensor weakness (e.g., FSHD, myotonic dystrophy)

2.5 Respiratory Physiotherapy

Respiratory physiotherapy is life-prolonging in MD, particularly DMD.

Secretion Clearance Techniques

TechniqueIndication
Manually Assisted Cough (MAC)PCF 160–270 L/min
Mechanical Insufflation-Exsufflation (MI-E / CoughAssist)PCF <160 L/min; acute illness
Active Cycle of Breathing Technique (ACBT)Ambulant patients with adequate effort
Positive Expiratory Pressure (PEP)Secretion mobilization
Postural drainageAs clinically indicated
High-frequency chest wall oscillation (HFCWO)Where available

Breath Stacking / Lung Volume Recruitment (LVR)

  • Used to increase peak cough flow and prevent progressive atelectasis
  • Manual Ambu bag stacking, glossopharyngeal breathing
  • Indicated when MIC (Maximum Insufflation Capacity) > FVC

Ventilatory Support

  • Non-invasive ventilation (NIV): first-line when FVC <50% predicted, symptomatic nocturnal hypoventilation, or SpO₂ <95%
  • Physiotherapy role: education, mask fitting, tolerance training, troubleshooting
  • Tracheostomy ventilation (invasive): considered when NIV becomes insufficient

2.6 Mobility and Assistive Technology

  • Walking aids: progression from no aids → forearm crutches → rollator
  • Power wheelchair: when ambulation ceases; tilt-in-space, headrest, pressure relief
  • Manual wheelchair: for transport/caregiver-assisted mobility
  • Adaptive seating: custom moulded seating for scoliosis/poor trunk control
  • Environmental control systems: smart home technology for late-stage non-ambulant patients
  • Hoists and transfer aids: ceiling track hoists, standing transfers
  • Communication aids: where upper limb function is severely limited

2.7 Postural Management and Seating

  • Critical in non-ambulant stage to manage scoliosis, pressure ulcer risk, and respiratory function
  • Tilt-in-space wheelchair to redistribute pressure
  • Lateral supports, thoracic supports for scoliosis
  • Pressure mapping to optimize seating
  • Regular repositioning schedule; education of caregivers
  • Avoid prolonged sitting in kyphotic or asymmetric postures

2.8 Pain Management

  • Postural correction and ergonomic advice
  • TENS, heat/cold therapy
  • Aquatic therapy for pain relief
  • Education on activity pacing
  • Referral to pain specialist if neuropathic component (especially myotonic dystrophy)

2.9 Fatigue Management

Fatigue is prevalent in MD and distinct from weakness.
  • Activity pacing: energy conservation strategies, rest breaks
  • Graded activity programs: avoiding boom-bust cycles
  • Prioritization of activities
  • Assistive devices to reduce energy expenditure
  • Sleep hygiene; address nocturnal hypoventilation

2.10 Falls Prevention

  • Balance training (proprioception, postural reactions) within safe limits
  • Hip protectors
  • Environmental modifications (remove trip hazards, grab rails)
  • Education on safe falling technique and floor transfers
  • Emergency call systems

2.11 Aquatic Physiotherapy

  • Particularly beneficial when land-based exercise is limited
  • Reduces joint stress, allows greater range of movement
  • Improves respiratory function (hydrostatic pressure on chest wall)
  • Psychological benefits
  • Precautions: monitor fatigue closely; ensure pool exit strategy for non-ambulant patients; avoid if respiratory reserve is critically low

2.12 Palliative and End-Stage Care

  • Comfort positioning and pressure care
  • Respiratory symptom management (dyspnea, secretion burden)
  • Communication support
  • Caregiver education and support
  • Liaison with palliative care team
  • Quality of life focus over functional gains

Part 3: Disease-Specific Considerations

Duchenne Muscular Dystrophy (DMD)

  • Most extensively researched; evidence base is strongest
  • Corticosteroids (deflazacort/prednisolone): slow progression; physiotherapy must account for steroid-related effects (obesity, osteoporosis, vertebral fractures)
  • Maintain ambulation as long as possible (walking prolongs lung and spine health)
  • Transition to KAFO + spinal bracing when knees start to buckle
  • Spinal surgery (posterior spinal fusion): when Cobb angle >20° and FVC >30%; physiotherapy is critical pre- and post-operatively
  • Cardiac physiotherapy input (heart failure management, exercise prescription)

Becker MD

  • Slower progression; many remain ambulant into adulthood
  • Similar principles as DMD but less aggressive timeline
  • Cardiac involvement (dilated cardiomyopathy) often precedes severe weakness — exercise prescription must account for cardiac status

Facioscapulohumeral (FSHD)

  • Scapular stabilization exercises
  • Scapular fixation surgery considered in severe cases
  • Foot drop: AFO
  • Pain management prominent (chronic pain is a major complaint)
  • Asymmetric weakness; individual assessment critical

Limb-Girdle MD (LGMD)

  • Wide heterogeneity between subtypes
  • General principles apply: proximal strengthening, stretch, aquatic therapy
  • Monitor respiratory and cardiac involvement by subtype

Myotonic Dystrophy (DM1/DM2)

  • Distal weakness (differentiates from most MDs); grip weakness, foot drop
  • Myotonia: grip myotonia, percussion myotonia — warm-up exercises, avoid cold
  • Fatigue and hypersomnia: fatigue management strategies essential
  • Dysphagia: speech and language therapy input, positioning for feeding
  • Cognitive and behavioural features: adjust communication and education accordingly
  • Respiratory involvement: often subclinical early; regular spirometry essential

Emery-Dreifuss MD

  • Early contractures (elbow flexors, Achilles, cervical extensors) even before significant weakness — aggressive stretching from diagnosis
  • Cardiac arrhythmias and conduction defects: exercise must be prescribed with cardiology guidance

Part 4: Goal-Setting and Outcome Monitoring

SMART Goals

Goals should be specific, measurable, achievable, relevant, time-bound, and aligned with the patient's own priorities.

Outcome Measures by Domain

DomainMeasure
StrengthHHD, MMT
Ambulation6MWT, 10MWT, NSAA, MFM-32
Upper limbPUL, Brooke Scale
RespiratoryFVC%, PCF, MIP, MEP
QoLPedsQL (children), SF-36, EQ-5D
FatigueFatigue Severity Scale
ParticipationACTIVLIM, PEDI

Monitoring Frequency (DMD example)

AssessmentFrequency
Timed functional tests, NSAAEvery 6 months
ROM/contracture assessmentEvery 6 months
Spirometry (FVC seated + supine)Every 6 months
Scoliosis screeningAnnually (or post-ambulation)
Cardiac reviewAnnually

Part 5: Multidisciplinary Team (MDT) Collaboration

Physiotherapy works alongside (Bailey & Love's, p. 652):
Team MemberRole
Neurologist/PaediatricianDiagnosis, disease monitoring, drug therapies
Respiratory PhysicianNIV initiation, sleep studies
CardiologistCardiac monitoring, medication
Orthopaedic SurgeonTendon release, scoliosis surgery
Occupational TherapistADL adaptations, upper limb function, equipment
Speech & Language TherapistDysphagia, communication
DietitianNutritional support (obesity with steroids, dysphagia)
Psychologist/Social WorkerAdjustment to disability, family support
Genetic CounsellorHeritability, family planning
PhysiotherapistComprehensive rehabilitation as above

Summary

Physiotherapy in muscular dystrophy is proactive, not reactive. The key principles are:
  1. Regular structured assessment using validated, disease-specific tools
  2. Safe, submaximal exercise — avoid eccentric overload and exhaustion
  3. Daily stretching to delay contractures
  4. Respiratory physiotherapy started early, progressed to assisted cough and NIV as FVC declines
  5. Orthotic management to prolong ambulation and prevent deformity
  6. Functional mobility and assistive technology optimization at each stage
  7. MDT collaboration throughout the disease course
  8. Stage-appropriate goals — shifting from preservation of function to quality of life and comfort in advanced disease
This is a shared conversation. Sign in to Orris to start your own chat.